Insights into the role of progesterone receptors in breast cancer

被引：27

作者：

Fuqua, SAW

Cui, YK

Lee, AV

Osborne, CK

Horwitz, KB

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Methodist Hosp, Houston, TX 77030 USA

[3] Univ Colorado, Sch Med, Denver, CO 80202 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 04期

关键词：

D O I：

10.1200/JCO.2005.05.152

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：931 / 932

页数：2

共 11 条

[1]

ABE O, 1992, LANCET, V339, P71

[2] Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases [J].

Bardou, VJ ;

Arpino, G ;

Elledge, RM ;

Osborne, CK ;

Clark, GM .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) :1973-1979

[3]

Baum M, 2002, LANCET, V359, P2131

[4] Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin pathway: Progesterone receptor as a potential indicator of growth factor activity in breast cancer [J].

Cui, XJ ;

Zhang, P ;

Deng, WL ;

Oesterreich, S ;

Lu, YL ;

Mills, GB ;

Lee, AV .

MOLECULAR ENDOCRINOLOGY, 2003, 17 (04) :575-588

[5]

DOWSETT M, 2003, BREAST CANC RES TREA, V82, pS10

[6] Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer [J].

Harvey, JM ;

Clark, GM ;

Osborne, CK ;

Allred, DC .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1474-1481

[7] Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates [J].

Hopp, TA ;

Weiss, HL ;

Hilsenbeck, SG ;

Cui, YK ;

Allred, DC ;

Horwitz, KB ;

Fuqua, SAW .

CLINICAL CANCER RESEARCH, 2004, 10 (08) :2751-2760

[8] Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A [J].

Mote, PA ;

Leary, JA ;

Avery, KA ;

Sandelin, K ;

Chenevix-Trench, G ;

Kirk, JA ;

Clarke, CL .

GENES CHROMOSOMES & CANCER, 2004, 39 (03) :236-248

[9] Time to stop progesterone receptor testing in breast cancer management [J].

Olivotto, IA ;

Truong, PT ;

Speers, CH ;

Bernstein, V ;

Allan, SJ ;

Kelly, SJ ;

Lesperance, ML .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1769-1770

[10]

OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO

← 1 2 →